<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Salmond N</submitter><funding>NSERC Discovery Grants Program</funding><pagination>326</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12534435</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>Diagnosis of stage 1 breast cancer is challenging as small tumors are often left undetected by conventional imaging techniques. In addition, ~80% of detected breast masses are classified as benign, which means that a large proportion of diagnostic needle biopsies lead to unnecessary psychological stress and medical costs. We investigated circulating extracellular vesicles (EVs) as potential carriers of unique cancer-associated proteins capable of reporting on a breast cancer diagnosis. We isolated EVs from healthy (19), benign (19), and stage 1 breast cancer patient (86) plasma samples using size exclusion chromatography. Mass spectrometry identified 94 significantly changed proteins in the plasma EVs from breast cancer patients. Analysis of a subset of these proteins using a cohort of pre</pubmed_abstract><journal>NPJ precision oncology</journal><pubmed_title>Circulating enolase 1 as a diagnostic biomarker for early-stage breast cancer.</pubmed_title><pmcid>PMC12534435</pmcid><funding_grant_id>RGPIN-04641</funding_grant_id><pubmed_authors>Moravcova R</pubmed_authors><pubmed_authors>Brackstone M</pubmed_authors><pubmed_authors>Watson PH</pubmed_authors><pubmed_authors>Lynn K</pubmed_authors><pubmed_authors>Salmond N</pubmed_authors><pubmed_authors>Williams KC</pubmed_authors><pubmed_authors>Rogalski JC</pubmed_authors><pubmed_authors>Tam WS</pubmed_authors><pubmed_authors>Khanna K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Circulating enolase 1 as a diagnostic biomarker for early-stage breast cancer.</name><description>Diagnosis of stage 1 breast cancer is challenging as small tumors are often left undetected by conventional imaging techniques. In addition, ~80% of detected breast masses are classified as benign, which means that a large proportion of diagnostic needle biopsies lead to unnecessary psychological stress and medical costs. We investigated circulating extracellular vesicles (EVs) as potential carriers of unique cancer-associated proteins capable of reporting on a breast cancer diagnosis. We isolated EVs from healthy (19), benign (19), and stage 1 breast cancer patient (86) plasma samples using size exclusion chromatography. Mass spectrometry identified 94 significantly changed proteins in the plasma EVs from breast cancer patients. Analysis of a subset of these proteins using a cohort of pre</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T13:50:01.672Z</modification><creation>2026-05-09T03:11:59.834Z</creation></dates><accession>S-EPMC12534435</accession><cross_references><pubmed>41107443</pubmed><doi>10.1038/s41698-025-01109-y</doi></cross_references></HashMap>